SGI heads into its Q1 2026 earnings call on May 13 with a sharp disconnect at the heart of its setup: short sellers have piled in aggressively over the past month, yet options traders have pivoted to one of the most bullish postures in the past year.
Short interest has climbed steeply since early April, rising 65% over the past month to reach 6.9% of the free float. The move started around April 9 — short positions roughly doubled from 7.6 million shares to above 13 million shares in under three weeks — and have held near that elevated level all through May. Days to cover now run at 5.6, and the lending market has tightened moderately with availability down compared to its 52-week high of 42%. That said, with cost to borrow running at a very manageable 0.48% and availability not yet at distressed levels, the borrow market signals deliberate positioning rather than a squeeze dynamic. The ORTEX short score has settled near 51 — mid-range, suggesting the market isn't treating this as an extreme short thesis.
Options tell an almost entirely different story. The put/call ratio has collapsed to 0.04, sitting near its 52-week low of 0.037 and nearly 1.5 standard deviations below the 20-day average of 0.15. Calls have overwhelmed puts by a wide margin all week. That kind of extreme call-heavy skew heading into an earnings print is unusual, and it stands in direct contrast to the month-long buildup in short positions. Something in the options market has clearly shifted post-May Day — the PCR was near 0.10 as recently as May 1 and compressed rapidly as the week progressed.
The Street is broadly constructive, though targets have been drifting lower. UBS has twice cut its price target in the past ten days — from $115 to $110 on April 30, then down again to $105 on May 8 — while holding its Buy rating. BofA trimmed its target from $106 to $96 in mid-April, also keeping Buy. Jefferies upgraded to Buy in late March while cutting the target to $88. The direction of travel is unambiguous: multiple houses still see meaningful upside from the current $69 level, but they're gradually marking down where "fair value" sits. The consensus mean target of $98.88 implies roughly 43% return potential — an unusually wide gap that likely reflects genuine uncertainty around the Mattress Firm integration and consumer spending trends rather than strong fundamental conviction. Goldman Sachs holds a Neutral rating with a stale $83 target from October 2025; given the intervening price moves and the tariff backdrop, that figure should be treated as directional at best.
The valuation picture has eased over the past month. The P/E multiple has compressed by roughly 1.99 turns to 20.1x over the past 30 days, and EV/EBITDA has slipped by about 1.0 turn to 14.1x. Neither ratio looks stretched in isolation, but the bear case points to a consumer discretionary company facing rising mortgage rates, pressured discretionary spending, and a heavy debt load following the Mattress Firm acquisition. The bull case rests on international diversification, post-acquisition synergies, and what proponents argue is a durable brand moat. The stock is down 8.3% on the week and 22% year-to-date — a meaningful re-rating that has made the numbers look more reasonable without fully resolving the fundamental debate.
The RSI14 has drifted to 36.7, close to oversold territory but not yet at an extreme. Closest peers IBP fell 24% on the week — the sharpest move in the group — while LEG dropped 7.6% and SKY shed 5.3%, suggesting sector-level selling pressure rather than an SGI-specific unwind. MHK was the lone bright spot, gaining 3.9% on the week.
With the Q1 2026 earnings call confirmed for May 13, the entire setup points to one number: the first disclosed result under the combined Somnigroup-Mattress Firm entity. The earnings history in the data shows a −11.8% single-day reaction on the most recent print — context that makes the current contrast between short positioning and bullish options flow all the more worth watching.
See the live data behind this article on ORTEX.
Open SGI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
